At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery
In Brief
A Phase 4 clinical trial evaluating Bupivacaine and Bupivacaine liposome suspension for Post-operative Pain and 2 related conditions. Completed, enrolled 51 participants across 1 site.
Detailed Summary
The purpose of the study is to evaluate the effect of Exparel on pain control and patient outcome after colon resection. The investigators will evaluate the clinical course of the patients who receive exparel as compared to the patients who do not receive exparel. Exparel is a 72 hour bupivacaine which is slowly released from lysosomes over the course of three days. A long acting local anesthetic should provide better pain control than conventional bupivacaine which has a 3.5 hour half-life.
Study Details
Timeline
Interventions
30ml of bupivacaine were injecting into the subcutaneous tissue at the incision sites after surgery in the OR
30ml of Bupivacaine liposome injectable suspension were injecting into the subcutaneous tissue at the incision sites after surgery in the OR